| View |
|
DR-XY13591
|
Proparacaine Hydrochloride
|
Alcaine
|
5mg/mL (0.5%)
|
Sterile Ophthalmic Solution
|
Local Anesthetic
|
Alcon Research, LLC
|
United States of America
|
Initial (Variation)
|
04 October 2022
|
04 October 2027
|
| View |
|
DR-XY13597
|
Nalidixic Acid
|
None
|
500 mg
|
Tablet
|
Antibacterial (Non-Fluorinated Quinolone)
|
Drugmakers Laboratories Inc.
|
Philippines
|
Automatic Renewal
|
05 April 2023
|
04 April 2028
|
| View |
|
DR-XY13598
|
Bromhexine Hydrochloride
|
None
|
5mg/ 5mL
|
Syrup (Strawberry Flavor)
|
Antitussive
|
Fortis Medi Pharmaceutical, Inc.
|
Philippines
|
Automatic Renewal
|
03 January 2022
|
27 February 2027
|
| View |
|
DR-XY13648
|
Paracetamol
|
Molpar
|
500 mg
|
Tablet
|
ANALGESIC/ ANTIPYRETIC
|
Drugmakers lab.Inc
|
Philippines
|
Renewal
|
06 October 2022
|
05 December 2027
|
| View |
|
DR-XY13655
|
Dexamethasone
|
Maxidex
|
1mg/ mL (0.1%)
|
Sterile Ophthalmic Suspension
|
Steroidal Anti-inflammatory
|
Alcon-Couvreur N.V.
|
Belgium
|
Automatic Renewal
|
22 July 2021
|
27 June 2026
|
| View |
|
DR-XY13657
|
Sodium Chloride
|
Salinase
|
0.0065
|
Buffered Solutions (Nasal Drops)
|
NASAL DECONGESTANT
|
EL LABORATORIES
|
Philippines
|
Automatic Renewal
|
17 January 2022
|
04 January 2027
|
| View |
|
DR-XY13670
|
L-Carnitine
|
Carnicor
|
0.1
|
Oral Solution
|
Amino Acid and Derivatives
|
Pascual Laboratories, Inc,
|
Philippines
|
Renewal
|
26 March 2024
|
14 May 2029
|
| View |
|
DR-XY13734
|
Lactated Ringer'S Solution
|
None
|
Each 100 mL contains 600 mg Sodium Chloride, 310 mg Sodium Lactate, Anhydrous, 30 mg Potassium Chloride & 20 mg Calcium Chloride, Dihydrate
|
Solution for IV Infusion
|
Rehydration Solution
|
EURO-MED LABORATORIES PHIL., INC.
|
Philippines
|
Automatic Renewal
|
03 November 2021
|
15 January 2027
|
| View |
|
DR-XY13764
|
Balanced Multiple Maintenance Solution With 5% Dextrose
|
Eurosol M in D5 Water
|
Each 100mL contains: Dextrose Monohydrate 5 g, Sodium Chloride 234 mg, Potassium Acetate 128 mg
Magnesium Acetate, Tetrahydrate 32.2 mg ,Sodium Metabisulfite (approx. 3 mEq/L) 30 mg
Electrolytes in 1L contains: Sodium 40 mEq, Potassium 13 mEq, Magnesium 3 mEq, Chloride 40 mEq, Acetate 16 mEq
|
Solution for IV Infusion
|
-
|
EURO-MED LABORATORIES PHIL., INC.
|
Philippines
|
Automatic Renewal
|
20 January 2022
|
15 January 2027
|
| View |
|
DR-XY13767
|
Tropicamide
|
Mydriacyl
|
5mg/ mL (5%)
|
Ophthalmic Solution
|
Mydriatic/Cycloplegic
|
S.A. Alcon Couvreur, N.V.
|
Belgium
|
Automatic Renewal
|
31 March 2021
|
25 June 2026
|
| View |
|
DR-XY13776
|
Betahistine mesylate
|
Vertilate
|
12 mg
|
Tablet
|
Antivertigo
|
Swiss Pharma Research Laboratories, Inc.
|
Philippines
|
Renewal
|
10 July 2024
|
06 December 2029
|
| View |
|
DR-XY13804
|
Water for Injection
|
Unbranded
|
None
|
Not Applicable
|
Parenteral
|
B. Braun Medical Industries Sdn. Bhd.
|
Malaysia
|
Renewal
|
16 March 2024
|
16 February 2029
|
| View |
DR-XY13867_PI_01.pdf
|
DR-XY13867
|
Budesonide
|
Budecort®
|
200mcg/ dose
|
Powder for Inhalation
|
Anti-asthma
|
AstraZeneca AB
|
Sweden
|
Automatic Renewal
|
04 January 2022
|
03 April 2027
|
| View |
|
DR-XY13927
|
5% Dextrose in Lactated Ringer's
|
None
|
Each 100-mL contains 5 g Dextrose Monohydrate, 600 mg Sodium Chloride, 310 mg Sodium Lactate, Anhydrous, 30 mg Potassium Chloride & 20 mg Calcium Chloride, Dihydrate
|
Solution for IV Infusion
|
-
|
EURO-MED LABORATORIES PHIL., INC.
|
Philippines
|
Automatic Renewal
|
28 February 2022
|
23 May 2027
|
| View |
|
DR-XY13928
|
Peritoneal Dialysis With 1.5% Dextrose
|
Europersol
|
Each 100 mL contains 1.5 g Dextrose Monohydrate, 550 mg Sodium Chloride, 392 mg Sodium Lactate Anhydrous, 25.7 mg Calcium Chloride Dihydrate & 15.2 mg Magnesium Chloride Hexahydrate
|
Dialysis Solution
|
-
|
EURO-MED LABORATORIES PHIL., INC.
|
Philippines
|
-
|
18 April 2022
|
14 October 2027
|
| View |
|
DR-XY13937
|
Balanced Multiple Replacement Solution With 5% Dextrose
|
Eurosol-R In D5 Water
|
Each 100 mL contains: Dextrose Monohydrate 5g, Sodium Chloride 573 mg, Sodium Acetate, Anhydrous 346 mg, Potassium Acetate 49 mg, Magnesium Acetate, Tetrahydrate 32.2 mg, Sodium Metabisulfite (approx. 3 mEq/L) 30 mg
|
Solution For Iv Infusion
|
-
|
Euro-Med Laboratories Phil., Inc.
|
Philippines
|
Automatic Renewal
|
11 April 2022
|
27 October 2027
|
| View |
|
DR-XY13950
|
Salbutamol
|
Unbranded
|
2mg/5mL
|
Syrup
|
Bronchodilators
|
Philmed Laboratories, Inc.
|
Philippines
|
Renewal
|
05 January 2024
|
11 March 2029
|
| View |
|
DR-XY14043
|
Atenolol
|
Tenormin®
|
50 mg
|
Tablet
|
Selective Beta-adrenoceptor Blocker
|
Corden Pharma GmbH
|
Germany
|
Initial (Variation)
|
02 July 2024
|
02 July 2029
|
| View |
DR-XY14048_PI_01.pdf
|
DR-XY14048
|
Tamoxifen (as citrate)
|
Nolvadex-D
|
20 mg
|
Tablet
|
Antineoplastic
|
AstraZeneca UK Limited
|
United Kingdom
|
Renewal
|
16 January 2024
|
03 June 2029
|
| View |
|
DR-XY14078
|
Propranolol Hydrochloride
|
Inderal
|
10 mg
|
Tablet
|
Non-selective Beta-adrenoceptor blocker
|
AstraZeneca Pharmaceutical Co. Ltd.
|
China
|
Automatic Renewal
|
18 April 2023
|
22 June 2028
|